" /> Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 - CISMeF





Preferred Label : Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19;

NCIt synonyms : CTL119 Cells; huCART19 T-lymphocytes; Anti-CD19 CAR-T Cells huCART19; Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells huCART19; huCART19 Cells; Anti-CD19 Humanized scFv TCRz-41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytes;

NCIt definition : Autologous T-lymphocytes that have been transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) consisting of a humanized single chain variable fragment (scFv) of anti-CD19 coupled to the cytoplasmic portion of the zeta chain of the human T-cell receptor (CD3zeta) and the co-stimulatory molecule 4-1BB (CD137), with potential immunostimulating and antineoplastic activities. Upon re-introduction into the patient, the autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 target and bind to CD19-expressing neoplastic B-cells. This results in a cytotoxic T-lymphocyte (CTL) response against CD19-expressing tumor cells, resulting in tumor cell lysis. CD19 (cluster of differentiation 19) is a B-cell-specific cell surface antigen overexpressed in B-cell lineage tumors. Incorporation of the co-stimulatory signaling domains increases human T-cell function, expansion, and survival.;

Molecule name : CTL119;

NCI Metathesaurus CUI : CL562996;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.